Search results for "Acute"

showing 10 items of 2516 documents

Impact of pre-hospital renal function on the detection of acute kidney injury in acute decompensated heart failure.

2019

Acute kidney injury (AKI) is a serious complication in patients hospitalized for decompensated heart failure (HF). Currently, AKI definitions consider creatinine levels at admission as reference of baseline renal function (RF). However, renal impairment may already be present at admission. We aimed to study the impact on AKI detection of considering outpatient RF as reference.In a cohort of 458 patients hospitalized for decompensated HF, we studied the occurrence of AKI using the standardized KDIGO criteria and grading (stages: 1, 2, 3), and considering two different definitions according to the RF used as reference or baseline: the latest outpatient measurement prior to admission vs. the f…

medicine.medical_specialtyAcute decompensated heart failureRenal function030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRisk FactorsInternal MedicinemedicineHumans030212 general & internal medicineRetrospective StudiesHeart FailureCreatininebusiness.industryAcute kidney injuryAcute Kidney Injurymedicine.diseasefemale genital diseases and pregnancy complicationsHospitalschemistryHeart failureCreatinineEmergency medicineCohortRisk assessmentComplicationbusinessEuropean journal of internal medicine
researchProduct

Randomized, placebo-controlled, double-blind and open-label studies in the treatment and prevention of acute diarrhea with Enterococcus faecium SF68

2020

Enterococcus faecium SF68® (SF68) is a licensed pharmaceutical for treatment and prevention of diarrhea in Austria, Italy and Switzerland. However, as for other probiotics, evidence for its efficacy is based on small to medium-sized studies. Four unpublished studies on the treatment of acute diarrhea and the prevention of antibiotic-associated diarrhea were analyzed: one randomized, double blind, placebo-controlled trial (RCT) for treatment (n = 1,143), one open-label study for treatment (n = 5,093), one RCT for prevention (n = 1,397) and one open-label study for prevention (n = 4,340). Patients in the treatment-arm and the open-label studies received SF68 (b.i.d. for the prevention studies…

medicine.medical_specialtyAcute diarrheaEnterococcus faecium610 Medicine & health2700 General Medicinerandomized-controlled trialPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialpreventionlawInternal medicinemedicineClinical endpoint030212 general & internal medicineAdverse effectOriginal Researchlcsh:R5-920biologytreatmentbusiness.industryIncidence (epidemiology)SF68acute diarrheaGeneral Medicinebiology.organism_classificationDiarrhea10219 Clinic for Gastroenterology and HepatologyprobioticsMedicine030211 gastroenterology & hepatologymedicine.symptomlcsh:Medicine (General)businessEnterococcus faecium
researchProduct

Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease

2021

Noninvasive ventilation (NIV) represents the standard of care for respiratory support of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) developing acute hypercapnic respiratory failure (AHRF) [1]. NIV has been shown to reduce patient’s work of breathing and mortality and be feasibly implemented in various hospital location facilities at different timing, based on the severity of AHRF [2] and it is also widely used in clinical practice by physicians [3]. However, clinicians’ knowledge, experience and expertise in the management of NIV are crucial for its success in order to overcome common problems that may lower its effectiveness such as patients’ discomf…

medicine.medical_specialtyAcute hypercapnic respiratory failureacute respiratory failurehigh-flow nasal cannulabusiness.industryHealth PolicyPulmonary diseasenoninvasive ventilationPulmonary Disease Chronic ObstructiveCOPD exacerbationCopd exacerbationInternal medicineCardiologymedicineHumansNoninvasive ventilationAcute respiratory failureHigh flowbusinessNIV HFNTacute hypercapnic respiratory failure
researchProduct

Akute interstitielle Nephritis nach Piperacillin

1989

A 75-year-old woman developed fever, exanthema and nonoliguric renal failure 16 days after the beginning of Piperacillin treatment. Renal biopsy revealed lympho-plasmacellular acute interstitial nephritis (AIN). A lymphocyte-transformation-test showed significant stimulation of patient's lymphocytes by Piperacillin. Corticosteroid-therapy correlated to clinical and renal improvement. Nevertheless the patient died of foudroyant septicemia caused by E. coli. Our report describes the first immunologically documented case of AIN following Piperacillin treatment.

medicine.medical_specialtyAcute interstitial nephritismedicine.diagnostic_testbusiness.industryGeneral MedicineGastroenterologyMolecular medicineLymphocyte transformationInternal medicineDrug DiscoveryImmunologymedicineMolecular MedicineRenal biopsybusinessGenetics (clinical)Piperacillinmedicine.drugKlinische Wochenschrift
researchProduct

Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia

1969

SUMMARY Cardiorenal syndrome involves altering cardiac and renal function. These patients frequently develop resistance to diuretic therapy, so that ultrafiltration should be applied in emergency for saving them. Concomitant presence of an active hematologic malignancy represents an important complicating factor. We present the case of an elderly patient with acute myeloid leukemia, appeared on the background of myelodysplastic syndrome who, during marrow aplasia occurred after the first course of induction chemotherapy, developed a cardiorenal syndrome, which required repeated sessions of hemodialysis. Complete hematologic remission and efficiency of fluid depletion therapy allowed the sec…

medicine.medical_specialtyAcute leukemiaAcute leukemiabusiness.industrymedicine.medical_treatmentCardiorenal syndromeMyeloid leukemiaRenal functionInduction chemotherapyCase ReportGeneral MedicineCardiorenal syndromeAplasiamedicine.diseaseGastroenterologyCholesterolInternal medicineConcomitantHemodialysismedicineHemodialysisAcute hepatitisIntensive care medicinebusinessPakistan Journal of Medical Sciences
researchProduct

Do we Need a Triple Antibiotic Therapy?

2001

To compare the efficacy and toxicity of triple antibiotic therapy in patients undergoing autologous peripheral blood-stem-cell transplantation (PBSCT) with literature data.

medicine.medical_specialtyAcute leukemiabusiness.industryClostridium difficilemedicine.diseaseTransplantationInternal medicineAntibiotic therapyToxicitymedicineIn patientTriple AntibioticbusinessMultiple myeloma
researchProduct

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Ce…

2011

Abstract Abstract 4109 We have previously demonstrated that the application of CD8-depleted donor-lymphocyte infusions (DLI) is feasible after reduced-intensity conditioning and in vivo T-cell depletion by alemtuzumab. DLI overcome slow lymphocyte recovery associated with alemtuzumab-administration and improve anti-infectious immunity and reliably convert a decreasing T-cell chimerism (Meyer et al. Blood 2007 & BMT 2010). Here we provide clinical follow up data of 117 patients with different hematological diseases and a median observation time of 1 year (range, 1–86 months) post hematopoietic stem cell transplantation (HSCT). The majority of patients either suffered from an acute leukem…

medicine.medical_specialtyAcute leukemiabusiness.industrymedicine.medical_treatmentImmunologyContext (language use)Cell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseBiochemistryGastroenterologySurgeryTransplantationGraft-versus-host diseaseInternal medicinemedicineAlemtuzumabbusinessSurvival analysisMultiple myelomamedicine.drugBlood
researchProduct

Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.

2021

Abstract Aims Peripheral artery disease (PAD) patients suffer a high risk of major cardiovascular (CV) events, with athero-thrombo-embolism as the underlying pathophysiologic mechanism. Recently, two large randomized clinical trials evaluated the efficacy and safety of low-dose rivaroxaban twice daily plus aspirin in stable PAD outpatients and those immediately after peripheral revascularization. We sought to determine if the effects of low-dose rivaroxaban and aspirin compared to aspirin alone are consistent across this broad spectrum of PAD patients. Methods and results We conducted a random-effects meta-analysis of the COMPASS and VOYAGER randomized trials among 11 560 PAD patients (4996…

medicine.medical_specialtyAcute limb ischaemiaEpidemiologymedicine.medical_treatmentHemorrhageRevascularizationlaw.inventionBrain IschemiaPeripheral Arterial DiseaseRandomized controlled trialFibrinolytic AgentsRivaroxabanlawIschemiaInternal medicineMedicineHumansMyocardial infarctionAspirinRivaroxabanAspirinbusiness.industryHazard ratiomedicine.diseaseStrokeAmputationCardiologyDrug Therapy CombinationCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsEuropean journal of preventive cardiology
researchProduct

Mechanical rotational thrombectomy with Rotarex system augmented with drug-eluting balloon angioplasty vs. stenting for the treatment of acute thromb…

2018

Introduction Mechanical thrombectomy is an alternative to local thrombolysis for the treatment of severe ischaemia in the femoropopliteal segment, but stent implantation is usually required after this procedure. The use of drug-eluting balloons (DEBs) may overcome long-term problems associated with stents, but it remains unclear how often such a treatment is technically feasible and efficient. Aim This post hoc single-centre study was aimed at assessment of the feasibility, safety and efficacy of mechanical thrombectomy followed by application of DEBs. Material and methods Fifty-one patients, aged 69.1 ±11.6 years, were managed for acute thrombotic or chronic critical ischaemia in the femor…

medicine.medical_specialtyAcute limb ischaemiaUrologymedicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematologyBalloon03 medical and health sciencesmechanical thrombectomy0302 clinical medicineacute limb ischaemiaAngioplastymedicine030212 general & internal medicinecritical ischaemiaOriginal Paperbusiness.industryMortality ratelcsh:RGastroenterologyObstetrics and GynecologyStentThrombolysismedicine.diseaseSurgeryDissectiondrug-eluting balloonAmputationSurgerystentbusiness
researchProduct

Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical…

2006

Acute otitis media (AOM) is the most common bacterial infectious disease among children. Vaccination is proposed to prevent otitis and several clinical trials were performed to assess the efficacy of pneumococcal vaccines. The way vaccine efficacy is analysed varies among trials. However, the clinical meaning of an estimate of vaccine effect and its statistical test depends on the applied statistical method. We aim to bring the meaning and validity of statistical trial results to the attention of researchers. We consider all methodological approaches for analysing vaccine efficacy applied in pneumococcal vaccination trials included in a recent Cochrane Review. We demonstrate how different m…

medicine.medical_specialtyAcute otitis mediaPneumococcal InfectionsPneumococcal VaccinesmedicineHumansIntensive care medicineChildRandomized Controlled Trials as TopicGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryMiddle ear diseasePublic Health Environmental and Occupational HealthInfantVaccine efficacyClinical trialVaccinationOtitis MediaInfectious DiseasesOtitisInfectious disease (medical specialty)Research DesignChild PreschoolPneumococcal vaccinationImmunologyMolecular Medicinemedicine.symptombusinessVaccine
researchProduct